Scorpion Therapeutics is a precision oncology company developing small molecule drugs specifically designed to interact with validated cancer targets with greater selectivity and optimized pharmaceutical properties to improve their safety and efficacy. The company is well funded to rapidly develop its portfolio of drugs against known, high-impact oncogenes.